首頁 > 市場調查報告書 > 製藥

臨床實驗人工智能

市場調查報告書

商品編碼

1627576

臨床實踐中的人工智慧：預測（2025-2030）

AI in Clinical Settings Market - Forecasts from 2025 to 2030

出版日期: 2024年12月23日 | 出版商:

Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

臨床環境中的AI市場預計將以37.5%的複合年成長率成長。

臨床人工智慧市場的發展受到對改善患者治療效果和診斷效率的需求不斷成長以及醫療保健領域大量資料的推動。

它還在許多方面改變醫療保健，包括醫學影像分析、藥物開發、精準醫療、診斷和治療管理以及臨床影像處理。

此外，人工智慧可以透過識別適合所需治療的患者特徵來促進適當的治療處方。人工智慧輔助系統也為實際應用帶來臨床決策支持，使醫療保健專業人員能夠做出決策。

臨床實務中人工智慧的市場促進因素

醫療成本上漲

醫療費用上漲是醫療保健系統面臨的全球性問題。這些與多種因素有關，包括人口老化、技術創新、行政複雜性、藥物成本、防禦性醫療以及醫療保健效率低下。此外，根據“2030願景”計劃，沙烏地阿拉伯政府將投資超過650億美元發展醫療基礎設施，重組和私有化保險和醫療服務，並在全國建立21個“健康叢集”，並打算提高電子健康服務。同樣，其目標到 2030 年將私部門的參與率從 40% 提高到 65%。此舉將導致 290 家醫院和 2,300 家初級衛生中心私有化，為投資沙烏地阿拉伯不斷擴大的醫療保健市場的美國公司創造重大商機。

隨著人口老化，對醫療保健服務的需求日益成長，尤其是針對慢性疾病和與老齡化相關的疾病。需求的增加導致醫療資源緊張並推高了成本。此外，醫療索賠、計費和法規合規等管理成本也增加了成本負擔。

臨床環境中人工智慧的地理前景：

臨床 AI 市場分為全球五個區域：

根據地區，臨床環境中的人工智慧市場細分為北美、南美、歐洲、中東和非洲以及亞太地區。北美臨床環境中的人工智慧市場主要受到強大的醫療保健基礎設施、對醫療保健技術和研究的大量投資以及鼓勵創新和採用人工智慧解決方案的有利法規環境的推動。根據美國醫學會預測，2022年美國在醫療保健方面的支出將達到44644億美元，其中醫院佔30.4%，醫生服務佔14.5%，臨床服務佔5.3%，居家醫療佔3%。 4.3%）、處方藥（9.1%）、其他個人照護（16.5%）、醫療保險淨成本（6.3%）、政府行政（1.2%）和政府公共衛生活動（4.7%）以及投資（4.9%）。

同時，亞太地區臨床人工智慧市場受到多種因素推動，包括快速成長的醫療保健產業、龐大的人口和不斷上漲的醫療成本。慢性病發病率的上升以及政府支持人工智慧應用的措施和政策正在推動市場成長。例如，印度2016年報告了37,416例前列腺癌病例，2020年增加到41,532例。到 2025 年，前列腺癌病例數預計將增加到 47,000 多例。這一數字約佔全國所有癌症患者的3%。此外，印度前列腺癌的平均發病年齡為 69.7 歲。此外，可支配收入的增加以及醫療專業人士和患者對人工智慧益處的認知不斷提高，也促進了該地區市場的擴張。

為什麼要購買這份報告？

深刻的分析：獲得深入的市場洞察，涵蓋主要地區和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

2022 年至 2030 年的實際資料和預測
成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
競爭定位、策略與市場佔有率分析
各地區（包括細分市場和國家）的收益成長和預測分析
公司概況（策略、產品、財務、主要發展等）

世界概況
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 南美洲其他地區
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 其他中東和非洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 台灣
- 泰國
- 印尼
- 其他亞太地區

第8章競爭格局及分析

主要企業和策略分析
市場佔有率分析
合併、收購、協議和合作
競爭儀錶板

第9章公司簡介

IQVIA
AiCure
Google Health
DeepScribe
Siemens Healthineers
Nuance Communications
Care.ai
Qure AI
NVIDIA
Arm

簡介目錄

Product Code: KSI061617232

The AI in clinical settings market is anticipated to grow at a CAGR of 37.5%.

The AI in clinical settings market is growing significantly due to the enhanced requirements for improving patient outcomes and diagnostic efficiency and the large volume of data in health care.

It is also transforming health care from different fronts, such as medical image analysis, drug development, precision medication, diagnostic and treatment administration, and clinical image processing.

Moreover, AI promotes prescribing the right treatment by identifying patient characteristics to suit the required treatment. AI-aided systems also bring clinical decision support for practical uses, enabling healthcare professionals to arrive at decisions.

AI in the clinical settings market drivers:

Rising healthcare costs

The high cost of health care is a global problem for the healthcare system. These are associated with various factors such as the aging population, technological innovation, administrative complexities, cost of drugs, defensive medicine, and healthcare delivery inefficiency. In addition to this, the Saudi Arabian government intends to invest more than $65 billion under Vision 2030 to build its healthcare infrastructure, restructure and privatize insurance and health services, establish 21 "health clusters" nationwide, and increase the availability of e-health services. Similarly, private sector participation is aiming to increase from 40% to 65% by 2030. This would entail the privatization of 290 hospitals and 2300 primary health centers, thus creating considerable business opportunities for American companies investing in Saudi Arabia's expanding healthcare market.

With the aging population, demand for healthcare services expands, mainly in chronic diseases and age-related conditions. This increase in demand can strain healthcare resources while raising costs. Moreover, administrative costs such as healthcare insurance claims, billing, and regulatory compliance will increase the cost burden.

AI in clinical settings market geographical outlook:

The AI in clinical settings market is segmented into five regions worldwide:

Geography-wise, the market of AI in clinical settings is divided into North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The North American AI in clinical settings market is largely driven by a strong healthcare infrastructure, large-scale investment in healthcare technology and research, and an excellent regulatory environment that fosters innovation and adoption of AI-enabled solutions. According to the American Medical Association, the United States spent $4,464.4 billion on health care in 2022 which was divided into different segments out of which hospital care accounted for 30.4% share, followed by physician service (14.5%), clinical services (5.3%), home health care (3%), nursing care facilities (4.3%), prescription drugs (9.1%), other personal health care (16.5%), the net cost of health insurance (6.3%), government administration (1,2%), government public health activities (4.7%), and investment (4.9%).

On the other hand, several factors drive the Asia Pacific AI in the clinical settings market, including a rapidly growing healthcare sector, a large population, and rising healthcare costs. The increasing prevalence of chronic diseases and government initiatives and policies supporting AI adoption are accelerating market growth. For instance, India reported 37,416 cases of prostate cancer in 2016, and by 2020, that number had risen to 41,532 cases. By 2025, the incidence of prostate cancer is predicted to rise to over 47,000 cases. This figure represents approximately 3% of all cancer cases in the nation. Additionally, in India, the average age at which prostate cancer occurs is 69.7 years. Moreover, rising disposable incomes and growing awareness of AI's benefits among healthcare providers and patients are contributing to the regional market expansion.

Reasons for buying this report:-

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data & forecasts from 2022 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The AI in clinical settings market is segmented and analyzed as follows:

By Technology

Machine Learning
Natural Language Processing
Computer Vision
Robotics

By End-User

Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Research Institutions

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Middle East and Africa
Saudi Arabia
UAE
Rest of the Middle East and Africa
Asia Pacific
China
India
Japan
South Korea
Taiwan
Thailand
Indonesia
Rest of Asia-Pacific

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings
3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. The Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. AI IN CLINICAL SETTINGS MARKET BY TECHNOLOGY

5.1. Introduction
5.2. Machine Learning
5.3. Natural Language Processing
5.4. Computer Vision
5.5. Robotics

6. AI IN CLINICAL SETTINGS MARKET BY END-USER

6.1. Introduction
6.2. Hospitals and Clinics
6.3. Pharmaceutical and Biotechnology Companies
6.4. Medical Device Companies
6.5. Research Institutions

7. AI IN CLINICAL SETTINGS MARKET BY GEOGRAPHY

7.1. Global Overview
7.2. North America
- 7.2.1. United States
- 7.2.2. Canada
- 7.2.3. Mexico
7.3. South America
- 7.3.1. Brazil
- 7.3.2. Argentina
- 7.3.3. Rest of South America
7.4. Europe
- 7.4.1. United Kingdom
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Rest of Europe
7.5. Middle East and Africa
- 7.5.1. Saudi Arabia
- 7.5.2. United Arab Emirates
- 7.5.3. Rest of the Middle East and Africa
7.6. Asia-Pacific
- 7.6.1. China
- 7.6.2. India
- 7.6.3. Japan
- 7.6.4. South Korea
- 7.6.5. Taiwan
- 7.6.6. Thailand
- 7.6.7. Indonesia
- 7.6.8. Rest of Asia-Pacific